Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

Date:

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

The Genentech logo displayed at the company’s headquarters in San Francisco in a file photo. Justin Sullivan/Getty Images

Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.

Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.

spot_imgspot_imgspot_img

Share post:

More like this
Related

Hegseth Orders Review of US Force Posture in Europe, Warns NATO Laggards of Consequences

Secretary of War Pete Hegseth speaks ahead of a...

NDAA Proposal Targets Troop Mobile Data Risk After CENTCOM Warning

Social media apps are displayed on a mobile phone,...

US Builder Confidence for Newly Built Single-Family Homes Falls in June

A for sale sign in Irvine, Calif., on Sept....